Transduction of dendritic cell progenitors with a retroviral vector encoding viral interleukin-10 and enhanced green fluorescent protein allows purification of potentially tolerogenic antigen-presenting cells

Transplantation

Volumn 68, Issue 12, 1999, Pages 1903-1909

  Takayama, Takuya ^a   Tahara, Hideaki ^a,b   Thomson, Angus W ^a,b  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GENE PRODUCT; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; GREEN FLUORESCENT PROTEIN; INTERLEUKIN 10; INTERLEUKIN 4; VIRUS VECTOR;

ANIMAL CELL; ANTIGEN PRESENTING CELL; CONFERENCE PAPER; CONTROLLED STUDY; DENDRITIC CELL; FLOW CYTOMETRY; GENE TARGETING; GENE TRANSFER; GENETIC ENGINEERING; GENETIC TRANSDUCTION; GRAFT REJECTION; IMMUNOLOGICAL TOLERANCE; IMMUNOMODULATION; IMMUNOREGULATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RETROVIRUS;

EID: 0033611049     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199912270-00015     Document Type: Conference Paper

References (48)

1. Steinman RM. The dendritic cell system and its role in immunogenicity. Annu Rev Immunol 1991; 9: 271.
2. Steptoe RJ, Thomson AW. Dendritic cells and tolerance induction. Clin Exp Immunol 1996; 105: 397.
3. Banchereau J, Steinman RM. Dendritic cells and the control of immunity. Nature 1998; 392: 245.
4. Lu L, Khoury SJ, Sayegh MH, Thomson AW. Dendritic cell tolerogenicity and prospects for dendritic cell therapy of allograft rejection and autoimmunity. In: Lotze MT, Thomson AW, eds. Dendritic cells: biology and clinical applications. San Diego: Academic Press, 1999: 487.
5. -) induce alloantigen-specific hyporesponsiveness in murine T lymphocytes. Transplantation 1995; 60: 1539.
6. Rastellini C, Lu L, Ricordi C, Starzl TE, Rao AS, Thomson AW. GM-CSF stimulated hepatic dendritic cell progenitors prolong pancreatic islet allograft survival. Transplantation 1995; 60: 1366.
7. -) prolong cardiac allograft survival in non-immunosuppressed recipients. Transplantation 1996; 62: 649.
8. Hayamizu K, Huie P, Sibley RK, Strober S. Monocyte-derived dendritic cell precursors facilitate tolerance to heart allografts after total lymphoid irradiation. Transplantation 1998; 66: 1285.
9. Enk AH, Angeloni VL, Udey MC, Katz SI. Inhibition of Langerhans cell antigen-presenting function by IL-10: a role for IL-10 in induction of tolerance. J Immunol 1993; 151: 2390.
10. Steinbrink K, Wölfl M, Jonuleit H, Knop J, Enk AH. Induction of tolerance by IL-10-treated dendritic cells. J Immunol 1997; 159: 4772.
11. Lu L, Li W, Fu F, et al. Blockade of the CD40-CD40L pathway potentiates the capacity of donor-derived dendritic cell progenitors to induce long-term cardiac allograft survival. Transplantation 1997; 64: 1808.
12. Khoury SJ, Gallon L, Verburg RR, et al. Ex vivo treatment of antigen-presenting cells with CTLA4-Ig and encephalitogenic peptide prevents experimental autoimmune encephalomyelitis in the Lewis rat. J Immunol 1996; 157: 3700.
13. Austyn JM. The initiation of immune responses and allograft rejection. In: Rose ML, Yacoub MH, eds. Immunology of heart and lung transplantation. Boston: Little, Brown & Co., Ltd., 1993: 22.
14. Fiorentino DF, Bond MW, Mosmann TR. Two types of mouse helper T cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones. J Exp Med 1989; 170: 2081.
15. de Waal Malefyt R, Haanen J, Spits H, et al. Interleukin-10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via down-regulation of class II major histocompatibility complex expression. J Exp Med 1991; 174: 915.
16. Ding L, Linsley PS, Huang L-H, Germain RN, Shevach EM. IL-10 inhibits macrophage costimulatory activity by selectively inhibiting the up-regulation of B7 expression. J Immunol 1993; 151: 1224.
17. de Smedt T, Van Mechelen M, De Becker G, Urbain J, Leo O, Moser M. Effects of interleukin-10 on dendritic cell maturation and function. Eur J Immunol 1997; 27: 1229.
18. de Waal Malefyt R, Abrams J, Bennett B, Figdor C, de Vries JE. IL-10 inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J Exp Med 1991; 174: 1209.
19. Fiorentino DF, Zlotnik A, Mosmann TR, Howard M, O'Garra A. IL-10 inhibits cytokine production by activated macrophages. J Immunol 1991; 147: 3815.
20. Bogdan C, Vodovotz Y, Nathan C. Macrophage deactivation by interleukin-10. J Exp Med 1991; 174: 1549.
21. Buelens C, Verhasselt V, De Groote D, Thielemans K, Goldman M, Willems F. Human dendritic cell responses to lipopolysaccharide and CD40 ligation are differentially regulated by interleukin-10. Eur J Immunol 1997; 27: 1848.
22. Groux H, Cottrez F, Rouleau M, et al. A transgenic model to analyze the immunoregulatory role of IL-10 secreted by antigen-presenting cells. J Immunol 1999; 162: 1723.
23. Moore KW, Vieira P, Fiorentino DF, Trounstine ML, Khan JTA, Mosmann TR. Homology of cytokine synthesis inhibitory factor (IL-10) to the Epstein Barr virus gene BCRFI. Science 1990; 248: 1230.
24. de Waal Malefyt R, Moore KW. Interleukin-10. In: Thomson AW, ed. The cytokine handbook, third edition. San Diego: Academic Press, 1998: 333.
25. Muller A, Schmitt L, Raftery M, Schonrich G. Paralysis of B7 co-stimulation through the effect of viral IL-10 on T cells as a mechanism of local tolerance induction. Eur J Immunol 1998; 28: 3488.
26. Takayama T, Nishioka Y, Lu L, Lotze MT, Tahara H, Thomson AW. Retroviral delivery of viral interleukin-10 into myeloid dendritic cells markedly inhibits their allostimulatory activity and promotes the induction of T-cell hyporesponsiveness. Transplantation 1998; 66: 1567.
27. Bagley J, Aboody-Guterman K, Breakefield X, Iacomini J. Long-term expression of the gene encoding green fluorescent protein in murine hematopoietic cells using retroviral gene transfer. Transplantation 1998; 65: 1233.
28. Persons DA, Allay JA, Riberdy JM, et al. Use of the green fluorescent protein as a marker to identify and track genetically modified hematopoietic cells. Nature Med 1998; 4: 1201.
29. Zhang G, Gurtu V, Kain SR. An enhanced green fluorescent protein allows sensitive detection of gene transfer in mammalian cells. Biochem Biophys Res Commun 1996; 227: 707.
30. Bierhuizen MF, Westerman Y, Visser TP, Wognum AW, Wagemaker G. Green fluorescent protein variants as markers of retroviral-mediated gene transfer in primary hematopoietic cells and cell lines. Biochem Biophys Res Commun 1997; 234: 371.
31. Bierhuizen MF, Westerman Y, Visser TP, Dimjati W, Wognum AW, Wagemaker G. Enhanced green fluorescent protein as selectable marker of retroviral-mediated gene transfer in immature hematopoietic bone marrow cells. Blood 1997; 90: 3304.
32. Limon A, Briones J, Puig T, et al. High-titer retroviral vectors containing the enhanced green fluorescent protein gene for efficient expression in hematopoietic cells. Blood 1997; 90: 3316.
33. Ramiro AR, De Yebenes VG, Trigueros C, Carrasco YR, Toribio ML. Enhanced green fluorescent protein as an efficient reporter gene for retroviral transduction of human multipotent lymphoid precursors. Hum Gene Ther 1998; 9: 1103.
34. Liu Y, de Waal Malefyt R, Briere F, et al. The EBV IL-10 homologue is a selective agonist with impaired binding to the IL-10 receptor. J Immunol 1997; 158: 604.
35. Warren S, Pear GP, Nolan ML, et al. Production of high-titer helper-free retroviruses by transient transfection. Proc Natl Acad Sci USA 1993; 90: 8392.
36. Inaba K, Inaba M, Romani N, et al. Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor. J Exp Med 1992; 176: 1693.
37. Bahnson AB, Dunigan JT, Baysal BE, et al. Centrifugal enhancement of retroviral mediated gene transfer. J Virol Methods 1995; 54: 131.
38. Curiel-Lewandrowski C, Mahnke K, Labeur M, et al. Transfection of immature murine bone marrow-derived dendritic cells with the granulocyte-macrophage colony-stimulating factor gene potently enhances their in vivo antigen-presenting capacity. J Immunol 1999; 163: 174.
39. Knechtle SJ, Zhai Y, Fechner J. Gene therapy in transplantation. Transplant Immunol 1996; 4: 257.
40. Giannoukakis N, Thomson AW, Robbins PD. Gene therapy in transplantation. Gene Therapy 1999; 6: 1499.
41. Knechtle SJ, Wang J, Jiao S, Geissler EK, Sumimoto R, Wolff J. Induction of specific tolerance by intrathymic injection of recipient muscle cells transfected with donor class I major histocompatibility complex. Transplantation 1994; 57: 990.
42. Madsen JC, Superina RA, Wood KJ, Morris PH. Immunological unresponsiveness induced by recipient cells transfected with donor MHC genes. Nature 1988; 332: 161.
43. Sykes M, Sachs DH, Nienhuis AW, Pearson DA, Moulton AD, Bodine DM. Specific prolongation of skin graft survival following retroviral transduction of bone marrow with an allogeneic major histocompatibility complex gene. Transplantation 1993; 55: 197.
44. Qin L, Chavin KD, Ding Y, et al. Retrovirus-mediated transfer of viral IL-10 gene prolongs murine cardiac allograft survival. J Immunol 1996; 156: 2316.
45. DeBruyne LA, Li K, Chan SY, Qin L, Bishop DK, Bromberg JS. Lipid-mediated gene transfer of viral IL-10 prolongs vascularized cardiac allograft survival by inhibiting donor-specific cellular and humoral immune responses. Gene Therapy 1998; 5: 1079.
46. Drazan KE, Wu L, Olthoff KM, Jurim O, Busuttil RW, Shaked A. Transduction of hepatic allografts achieves local levels of viral IL-10 which suppress alloreactivity in vitro. J Surg Res 1995; 59: 219.
47. Apparailly F, Verwaerde C, Jacquet C, Auriault C, Sany J, Jorgensen C. Adenovirus-mediated transfer of viral IL-10 gene inhibits murine collagen-induced arthritis. J Immunol 1998; 160: 5213.
48. Coates T, Krishnan R, Russ GR. Human dendritic cells transfected with an adenoviral interleukin-10 construct strongly inhibit the mixed lymphocyte culture (MLC) [Abstract B59]. J Leukocyte Biol 1998; (suppl 2): 43.